Ctsk-KO Mouse
Common Name
Ctsk-KO
제품 ID
S-KO-01691
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-13038-Ctsk-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Ctsk-KO Mouse (카탈로그 번호 S-KO-01691)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Ctsk-KO
품종 계통계통 ID
KOCMP-13038-Ctsk-B6J-VB
유전자명
제품 ID
S-KO-01691
유전자 별칭
catK, Ms10q, MMS10-Q
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000015664
NCBI 전사체 ID
NM_007802
타겟 영역
Exon 2~4
유효 영역 크기
~2.1 kb
유전자 연구 개요
Cathepsin K (Ctsk), a cysteine protease, is well-known for its strong activity in degrading the extracellular matrix. It is closely related to osteoclast-mediated bone destruction and plays a role in bone resorption [3]. Mutations in the Ctsk gene have been linked to pycnodysostosis, a rare autosomal recessive skeletal dysplasia [5,6,7,8,9].
In a mouse model where Trp53 and Rb1 were ablated in Ctsk-expressing cells (Ctsk-Cre;Trp53f/f/Rb1f/f mice), the animals spontaneously developed osteosarcoma with age, and loss of Trp53/Rb1 in these cells promoted the expression and nuclear translocation of YAP/TAZ. Verteporfin, an inhibitor of YAP/TAZ signaling, delayed osteosarcoma progression in these mice [2]. In another mouse FeCl3 model, Ctsk deficiency prevented stress-related thrombosis, as Ctsk seemed to contribute to thrombosis possibly via modulating vascular inflammation, oxidative production, and apoptosis [4]. In castration-resistant prostate cancer (CRPC), Ctsk was significantly up-regulated, and it regulated tumor growth and metastasis through the IL-17/CTSK/EMT axis and mediated M2 macrophage polarization [1].
In summary, Ctsk is crucial for extracellular matrix degradation and bone resorption. Gene-modified mouse models, such as Ctsk-Cre;Trp53f/f/Rb1f/f and Ctsk-deficient mice, have revealed its roles in osteosarcoma development, stress-related thrombosis, and CRPC, providing potential therapeutic targets for these diseases.
References:
1. Wu, Ning, Wang, YouZhi, Wang, KeKe, Liang, JiaMing, Jiang, Ning. 2022. Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer. In Cell death & disease, 13, 813. doi:10.1038/s41419-022-05215-8. https://pubmed.ncbi.nlm.nih.gov/36138018/
2. Li, Yang, Yang, Shuting, Yang, Shuying. 2022. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway. In Cells, 11, . doi:10.3390/cells11081361. https://pubmed.ncbi.nlm.nih.gov/35456040/
3. Gao, Li-Hong, Li, Shan-Shan, Yue, Hua, Zhang, Zhen-Lin. 2020. Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women. In Frontiers in endocrinology, 11, 48. doi:10.3389/fendo.2020.00048. https://pubmed.ncbi.nlm.nih.gov/32117071/
4. Jin, Xueying, Yue, Xueling, Huang, Zhe, Kuzuya, Masafumi, Cheng, Xian Wu. 2024. Cathepsin K deficiency prevented stress-related thrombosis in a mouse FeCl3 model. In Cellular and molecular life sciences : CMLS, 81, 205. doi:10.1007/s00018-024-05240-0. https://pubmed.ncbi.nlm.nih.gov/38703204/
5. Markova, Tatiana Vladimirovna, Kenis, Vladimir, Melchenko, Evgeniy, Nagornova, Tatiana, Dadali, Elena Leonidovna. 2022. Clinical and genetic characterization of three Russian patients with pycnodysostosis due to pathogenic variants in the CTSK gene. In Molecular genetics & genomic medicine, 10, e1904. doi:10.1002/mgg3.1904. https://pubmed.ncbi.nlm.nih.gov/35315254/
6. Huang, Xianglan, Qi, Xuan, Li, Mei, Hu, Ying Ying, Xia, Weibo. 2015. A Mutation in CTSK Gene in an Autosomal Recessive Pycnodysostosis Family of Chinese Origin. In Calcified tissue international, 96, 373-8. doi:10.1007/s00223-015-9963-y. https://pubmed.ncbi.nlm.nih.gov/25725806/
7. Sait, Haseena, Srivastava, Priyanka, Gupta, Neerja, Pabbati, Jayalakshmi, Phadke, Shubha R. 2021. Phenotypic and genotypic spectrum of CTSK variants in a cohort of twenty-five Indian patients with pycnodysostosis. In European journal of medical genetics, 64, 104235. doi:10.1016/j.ejmg.2021.104235. https://pubmed.ncbi.nlm.nih.gov/33945887/
8. Xue, Y, Wang, L, Xia, D, Mao, T, Duan, X. 2015. Dental Abnormalities Caused by Novel Compound Heterozygous CTSK Mutations. In Journal of dental research, 94, 674-81. doi:10.1177/0022034515573964. https://pubmed.ncbi.nlm.nih.gov/25731711/
9. Naeem, Muhammad, Sheikh, Sabeen, Ahmad, Wasim. 2009. A mutation in CTSK gene in an autosomal recessive pycnodysostosis family of Pakistani origin. In BMC medical genetics, 10, 76. doi:10.1186/1471-2350-10-76. https://pubmed.ncbi.nlm.nih.gov/19674475/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.